Targeting epigenetic regulators induces transcription-replication conflicts to overcome ATR inhibitor resistance
Abstract Many cancer cells exhibit elevated replication stress and are highly dependent on ataxia telangiectasia and Rad3-related (ATR) kinase activity to maintain genomic stability and survival. While ATR inhibitors (ATRi) have great promise as therapeutic agents, intrinsic or acquired resistance will likely be a sign...